(VIANEWS) – Amphastar Pharmaceuticals (AMPH), Insulet (PODD), Intuitive Surgical (ISRG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Amphastar Pharmaceuticals (AMPH)
36.7% sales growth and 18.73% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $1.92.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 23.9. Meaning, the purchaser of the share is investing $23.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.73%.
2. Insulet (PODD)
23.2% sales growth and 12.88% return on equity
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Earnings Per Share
As for profitability, Insulet has a trailing twelve months EPS of $0.88.
PE Ratio
Insulet has a trailing twelve months price to earnings ratio of 180.31. Meaning, the purchaser of the share is investing $180.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.88%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 600% and 24.5%, respectively.
Yearly Top and Bottom Value
Insulet’s stock is valued at $158.67 at 16:22 EST, way below its 52-week high of $335.91 and above its 52-week low of $152.43.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Insulet’s EBITDA is 676.48.
Moving Average
Insulet’s value is way under its 50-day moving average of $208.29 and way below its 200-day moving average of $275.97.
Previous days news about Insulet(PODD)
- : insulet shares rise as analysts say weight-loss drug fears May be overblown. According to MarketWatch on Monday, 2 October, "But the company’s disposable patch pump is winning market share as it provides convenience to patients and recent trends in prescription data and physician feedback suggest that Insulet can deliver strong results in the coming quarters, the analysts wrote. "
3. Intuitive Surgical (ISRG)
15.7% sales growth and 12.05% return on equity
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $3.95.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 72.75. Meaning, the purchaser of the share is investing $72.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.05%.
Volume
Today’s last reported volume for Intuitive Surgical is 462606 which is 74.12% below its average volume of 1788010.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 6.66B for the twelve trailing months.
Previous days news about Intuitive Surgical(ISRG)
- According to MarketWatch on Monday, 2 October, "He also pointed to Intuitive Surgical Inc. , which is employing AI and algorithms to help doctors predict the outcomes of surgeries. "
4. HighPeak Energy (HPK)
14.4% sales growth and 23.92% return on equity
HighPeak Energy, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids reserves in the Midland Basin in West Texas. As of December 31, 2020, the company had approximately 22,515 MBoe of proved reserves. HighPeak Energy, Inc. was founded in 2019 and is headquartered in Fort Worth, Texas.
Earnings Per Share
As for profitability, HighPeak Energy has a trailing twelve months EPS of $2.05.
PE Ratio
HighPeak Energy has a trailing twelve months price to earnings ratio of 7.79. Meaning, the purchaser of the share is investing $7.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.92%.
Yearly Top and Bottom Value
HighPeak Energy’s stock is valued at $15.96 at 16:22 EST, way below its 52-week high of $30.15 and way higher than its 52-week low of $10.44.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.5%, now sitting on 926.58M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 42.4% and positive 1.9% for the next.
5. CME Group (CME)
8.5% sales growth and 10.67% return on equity
Considering advanced prints from CME Group for gold futures markets, open interest increased for the second session in a row on Monday, this time by around 1.3K contracts.
Although the revised Summary of Economic Projections showed that the majority of policymakers saw it appropriate to raise the policy rate one more time before the end of the year, market participants are still pricing in a more than 50% probability that the interest rate will be held steady at the 5.25%-5.5% range this year, according to the CME Group FedWatch Tool.
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, CME Group has a trailing twelve months EPS of $8.19.
PE Ratio
CME Group has a trailing twelve months price to earnings ratio of 24.49. Meaning, the purchaser of the share is investing $24.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.67%.
Sales Growth
CME Group’s sales growth is 8.8% for the ongoing quarter and 8.5% for the next.
6. Booking Holdings (BKNG)
7.6% sales growth and 267.13% return on equity
Booking Holdings Inc. provides travel and restaurant online reservation and related services worldwide. The company operates Booking.com, which offers online accommodation reservations; Rentalcars.com that provides online rental car reservation services; and Priceline, which offer online travel reservation services, and consumers hotel, flight, and rental car reservation services, as well as vacation packages, cruises, and hotel distribution services. It also operates Agoda that provides online accommodation reservation services, as well as flight, ground transportation and activities reservation services. In addition, the company operates KAYAK, an online meta-search service that allows consumers to search and compare travel itineraries and prices, comprising airline ticket, accommodation reservation, and rental car reservation information; and OpenTable for booking online restaurant reservations. Further, it offers travel-related insurance products, and restaurant management services to consumers, travel service providers, and restaurants; and advertising services. The company was formerly known as The Priceline Group Inc. and changed its name to Booking Holdings Inc. in February 2018. The company was founded in 1997 and is headquartered in Norwalk, Connecticut.
Earnings Per Share
As for profitability, Booking Holdings has a trailing twelve months EPS of $113.3.
PE Ratio
Booking Holdings has a trailing twelve months price to earnings ratio of 26.59. Meaning, the purchaser of the share is investing $26.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 267.13%.
Volume
Today’s last reported volume for Booking Holdings is 116939 which is 58.55% below its average volume of 282125.
7. FirstService Corporation (FSV)
5.9% sales growth and 14.19% return on equity
FirstService Corporation, together with its subsidiaries, provides residential property management and other essential property services to residential and commercial customers in the United States and Canada. The company operates in two segments, FirstService Residential and FirstService Brands. The FirstService Residential segment offers property management services for private residential communities, such as condominiums, co-operatives, homeowner associations, master-planned communities, active adult and lifestyle communities, and various other residential developments. This segment also provides a range of ancillary services, including on-site staffing for building engineering and maintenance, full-service swimming pool and amenity management, and security and concierge/front desk; and financial services comprising cash management, other banking transaction-related, and specialized property insurance brokerage. In addition, this segment offers energy management solutions and advisory services, and resale processing services. The FirstService Brands segment provides property services through 5 franchise networks; and company-owned locations, including 19 California Closets and 11 Paul Davis Restoration locations. It provides residential and commercial restoration, painting, and floor coverings design and installation services; custom-designed and installed closet, and home storage solutions; home inspection services; and fire protection and related services. This segment offers its services primarily under the Paul Davis Restoration, Interstate Restoration, FirstOnSite Restoration, Century Fire Protection, CertaPro Painters, California Closets, Pillar to Post Home Inspectors, and Floor Coverings International brand names. FirstService Corporation was founded in 1989 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, FirstService Corporation has a trailing twelve months EPS of $2.99.
PE Ratio
FirstService Corporation has a trailing twelve months price to earnings ratio of 51.62. Meaning, the purchaser of the share is investing $51.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 4.12B for the twelve trailing months.
